Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moreau

Showing results (171-180 of 787) with videos related to

Pageof 79
Sort By:
Haematologica|September 5, 2008
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myelomaPhilippe Moreau, Valerie Coiteux, Cyrille Hulin, et al.
Nature Communications|January 4, 2019
Acto-myosin force organization modulates centriole separation and PLK4 recruitment to ensure centriole fidelityElisa Vitiello, Philippe Moreau, Vanessa Nunes, et al.
Data in Brief|July 14, 2025
High temperature stress-strain data for SAE 5120 steel under various strain ratesPhilippe Moreau, Jean-Dominique Guérin, José Grégorio La Barbara Sosa, et al.
Immunology|July 20, 2019
The Autoimmune Regulator (Aire) transactivates HLA-G gene expression in thymic epithelial cellsBreno Luiz Melo-Lima, Isabelle Poras, Geraldo Aleixo Passos, et al.
Expert Review of Clinical Pharmacology|October 28, 2015
Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomesPaul G Richardson, R Donald Harvey, Jacob P Laubach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2010
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS groupCaroline Bodet-Milin, Cyrille Touzeau, Christophe Leux, et al.
Blood|August 15, 2002
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyPhilippe Moreau, Thierry Facon, Xavier Leleu, et al.
Biomedical Optics Express|November 5, 2020
Single-shot hybrid photoacoustic-fluorescent microendoscopy through a multimode fiber with wavefront shapingSylvain Mezil, Antonio M Caravaca-Aguirre, Edward Z Zhang, et al.
Haematologica|May 12, 2004
Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myelomaPhilippe Moreau, Nelly Robillard, Herve Avet-Loiseau, et al.
Cancer Biology & Therapy|December 18, 2014
Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroupsPatricia Gomez-Bougie, Maxime Halliez, Sophie Maïga, et al.
Pageof 79

Showing results (171-180 of 787) with videos related to

Sort By:
Pageof 79
Haematologica|September 5, 2008
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myelomaPhilippe Moreau, Valerie Coiteux, Cyrille Hulin, et al.
Nature Communications|January 4, 2019
Acto-myosin force organization modulates centriole separation and PLK4 recruitment to ensure centriole fidelityElisa Vitiello, Philippe Moreau, Vanessa Nunes, et al.
Data in Brief|July 14, 2025
High temperature stress-strain data for SAE 5120 steel under various strain ratesPhilippe Moreau, Jean-Dominique Guérin, José Grégorio La Barbara Sosa, et al.
Immunology|July 20, 2019
The Autoimmune Regulator (Aire) transactivates HLA-G gene expression in thymic epithelial cellsBreno Luiz Melo-Lima, Isabelle Poras, Geraldo Aleixo Passos, et al.
Expert Review of Clinical Pharmacology|October 28, 2015
Panobinostat for the treatment of relapsed or relapsed/refractory multiple myeloma: pharmacology and clinical outcomesPaul G Richardson, R Donald Harvey, Jacob P Laubach, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2010
Prognostic impact of 18F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS groupCaroline Bodet-Milin, Cyrille Touzeau, Christophe Leux, et al.
Blood|August 15, 2002
Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapyPhilippe Moreau, Thierry Facon, Xavier Leleu, et al.
Biomedical Optics Express|November 5, 2020
Single-shot hybrid photoacoustic-fluorescent microendoscopy through a multimode fiber with wavefront shapingSylvain Mezil, Antonio M Caravaca-Aguirre, Edward Z Zhang, et al.
Haematologica|May 12, 2004
Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myelomaPhilippe Moreau, Nelly Robillard, Herve Avet-Loiseau, et al.
Cancer Biology & Therapy|December 18, 2014
Curcumin induces cell death of the main molecular myeloma subtypes, particularly the poor prognosis subgroupsPatricia Gomez-Bougie, Maxime Halliez, Sophie Maïga, et al.
Pageof 79